Marked elevation of transaminases and pancreatic enzymes in severe malnourished male with eating disorder by Urso, C. et al.
e387A case of severe malnourished male
Marked elevation of transaminases and pancreatic enzymes in 
severe malnourished male with eating disorder
C. Urso, S. Brucculeri, G. Caimi 
Department of Internal Medicine, University of Palermo, Palermo, Italy
Case report      Clin Ter 2013; 164 (5):e387-391.   doi: 10.7417/CT.2013.1619
Correspondence: Prof. Gregorio Caimi. Dipartimento di Medicina Interna  e Specialistica - Università degli Studi di Palermo, Via del Vespro 
129, 90127 Palermo, Italy. Tel. +39.091.6554406; Fax: +39.091 6554535. E-mail: gregorio.caimi@unipa.it
Copyright © Società Editrice Universo (SEU)
ISSN 1972-600
Introduction 
Chronic malnutrition is often complicated by endocrine 
dysregulation, fluid and electrolyte imbalances, cardiova-
scular and hemodynamic abnormalities, haematological 
disorders, osteopenia and osteoporosis, increased serum 
levels of transaminases, amylase and lipase that return 
within the normal range after an adequate nutritional and 
volaemic support. We report a case of a 45 year old Cauca-
sian malnourished male with an history of eating disorder 
who developed severe and unusual liver and pancreatic da-
mage. Although a moderate increase in liver and pancreatic 
enzymes are a common finding in malnourished patients, 
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only a small number of reports describes severe liver and 
multiorgan injury. 
 
Case report 
On November 2011, a 45 year old caucasian man with 
an history of eating disorder was admitted to  the emer-
gency department because of collapse. The biochemical 
analyses showed hypoglycemia associated with a marked 
increase in pancreatic and liver enzymes. He was tran-
sferred to our medical unit with the provisional diagnosis 
of “collapse and pancreatitis in an anorexic subject.” 
When the patient was 35 years old he weighed  70 kg and 
his body mass index (BMI) was 24.2 Kg/m2. At that time 
he underwent plastic surgery for pseudo-gynecomastia. 
Subsequently, he manifested sexual identity disorder as-
sociated with drastic changes in his dietary habits with 
an obsessive-phobic component, reduction of food intake 
and marked weight loss. For these reasons the patient had 
undertaken a discontinued diagnostic-therapeutic approach 
in a psychiatric clinic.
On January 2011, he was hospitalized in an internal 
medicine department for “severe malnutrition syndrome 
complicated by caloric-protein deficiency, myopathy and 
osteoporosis” and was discharged with a note to contact a 
specialized center in eating disorders, but the patient refu-
sed to continue the diagnostic therapeutic process. When 
the patient was admitted to our department his weight 
was 31 kg and his height  167 cm (BMI = 11,1 Kg/m2). 
Physical examination revealed poor trophic-nutritional 
state, body temperature of 35°C, blood pressure of 90/60 
mmHg, heart rate of 54 beats/min, SpO2 100%, dry skin 
and mucous membranes, anicteric sclerae, carotin icterus, 
scarse body hair, edema on the back of the foot, absence of 
subcutaneous fat, severe muscle hypotonia-hypotrophy with 
difficult ambulation, testicular hypotrophy. Cardiovascular, 
pulmonary and neurologic exams were normal. His chest 
showed severe kyphoscoliosis. His abdomen was scaphoid, 
with bowel sounds and without  hepatosplenomegaly. Initial 
laboratory values showed a leukocyte count of 3.04 x 103/
e388
                                                  C. Urso et al.
μl (n.v. 4-11) (neutrophils 87.8% -n.v, 40-74, lymphocytes 
8.9% - n.v. 20-48, monocytes 3.3% - n.v. 3-11), hemoglobin 
of 10,3 g/dL (n.v. 12-18) and a hematocrit of 30.4% (n.v. 
37-52); MCV was 93.8 fl (n.v. 80-99) and RDW 14.4% 
(n.v. 11-15); platelets count was of 39 x 103/μl (n.v. 150-
450). Serum electrolytes showed a natremia of 132 mEq/L 
(n.v 132-146) and potassium of 3.7 mEq/L (n.v. 3.7-5.4). 
Transaminases were elevated (AST 2291 U/L-n.v.< 37, ALT 
1792 U/L-n.v.< 41) associated with a marked increase in 
α-amylase (3620 U/L- n.v. 28-100), lipase (4102 U/L - n.v. 
13-60), lactate dehydrogenase (LDH 2082 U/L-n.v. 240-480) 
and creatine-phosphokinase (CPK 1370 U/L - n.v. <308). 
Serum alkaline phosphatase was  257 U/L (n.v. 40-129) and 
γ-glutamiltranspeptidase was of 171 U/L (n.v. 8-61). Total 
and conjugated bilirubin were 1.4 (n.v. <1.2) and 0.02 mg/
dl (n.v.<0.3) respectively, pseudocholinesterase was 2019 
U/L (n.v. 5320-12920) and albumin was of 3.4 g/dl (n.v. 
3.4-4.8). INR was 1.31 (n.v. 0.8-1.2); fasting plasma glucose 
was 33 mg/dl (n.v. 70-100) in absence of clinical symptoms. 
The ammonia value was 13 umol/L (n.v. 11-35), cyanoco-
balamin 2001 pg/ml (n.v. 180-900), folates 20 ng/ml (n.v. 
3-18), total vitamin D 11 ng/ml (n.v.15-80), ferritin 1045 
ng/ml (n.v. 30-400) and serum iron 54 mcg/dl (n.v. 58-158). 
Fecal haemoccult was negative. The hormonal parameters 
showed mild hypercortisolism (cortisol at 8:00 am was 26 
g/dl n.v. 6.2-19.4 and cortisol at 06:00 pm was 13 mg/dl 
n.v. 2.3 - 11.9), GH was at the upper limit (5.23 ng/ml - n.v. 
0-6) and the values of thyroid hormones (TSH 2.35 μUI/ml 
-n.v. 0,27-4,2; FT4: 1.59 ng/dl -n.v. 0,9-1,7; FT3: 2.9 pg/
ml -n.v. 2-4.4) were normal. Testosterone value was 0.39 
ng/ml (n.v. 2.4-8.3); FSH: 3.92 mIU/ml (n.v. 1.5-12.4); LH: 
2.49 mIU/ml (n.v. 1.7-8.6). Parathormone value was 196 
pg/ml (n.v. 11-54). Urine analysis was normal. Creatinine 
clearance was 107 ml/min. The electrocardiogram showed 
sinus bradycardia (55 beats/minute).
Radiographic test revealed severe osteopenia and multi-
ple vertebral and sacral fractures. The densitometry values 
showed a T-score of -3.3 SD and a Z score of -3.1 SD in 
lumbar vertebrae. At  proximal portion of the left femur 
T-score was -3.1 SD and Z-score -2.9 SD. Psychiatric exa-
mination revealed: “a normo-oriented subject, emotionally 
labile, irritable, suspicious, sometimes hostile, manipulative; 
evidence of schizotypical traits of personality with obsessive 
ideation and erroneous beliefs about the somatic self and 
unadequate reality testing”.
The common causes of liver and pancreatic injury were 
excluded; there was no history of alcohol abuse, use of drugs 
or toxic substances. Serologic tests for the major hepatotro-
pic viruses (hepatitis viruses A, B and C, Cytomegalovirus, 
Epstein-Barr virus), for HIV and parvovirus were negative. 
Imaging studies (ultrasound, computed tomography and 
nuclear magnetic resonance) failed to demonstrate any ab-
normalities in liver, pancreas, gallbladder and biliary tract 
morphology.
Clinical course
The initial medical treatment included intavenous 
infusion of 10% glucose solution (1500 cc/day). Starting 
on the third hospital day parenteral nutrition was initiated 
later associated with oral nutrition. During the first week of 
treatment infusion of sodium phosphate, magnesium sulfate 
and thiamine was necessary. After a few days of treatment a 
marked decrease in levels of transaminases, lipase, amylase, 
CPK and LDH occurred, despite an initial and further incre-
ase in these levels. At the second week of hospitalization an 
increase in edema of the lower extremities in association with 
a decrease in the levels of hemoglobin (6.2 g/dl), hematocrit 
(18%) and albumin (1.7 g/dl) occurred, probably consequent 
to the refeeding syndrome. Therefore, we reduced his caloric 
and water intake, infused albumin and low doses of furose-
mide; subsequently the edema disappeared. After transfusion 
with red blood cells and erythropoietin therapy (12000 IU/
week) hemoglobin levels increased to around 10 g/dl. From 
the third hospital week, a rapid increase in the platelet count 
occurred and it gradually returned to normal. At discharge, 
after a 26-day hospitalization, the patient had a body weight 
of 32 kg (BMI = 11.5), the clinical and laboratory parameter 
had improved (AST 38 U/L, ALT 27 U/L, total bilirubin 0.9 
mg/dl, alkaline phosphatase 221 U/L, γ-GT 36 U/L, LDH 
504 U/L, CPK 39 U/L, α-amylase 262 U/L, lipase 256 U/L, 
hemoglobin 10.1 g/dl, WBC 4.02 x 103/ul, platelets 220 x 
103/ul (Fig. 1). After physiotherapy, the patient had largely 
regained his ability to walk independently. On the basis of 
the psychiatric consultation olanzapine 5 mg/die had been 
started and the patient was referred to a specialized center 
for eating disorders.
Discussion
On admission the patient showed an eating disorder 
which was secondary to a schizotypical personality with 
erroneous beliefs about the somatic self, obsessive ideas, 
sitophobia and  absence of DSM-IV criteria for the anorexia 
nervosa diagnosis. The latter can not however be excluded 
because of the absence of anamnestic data about the onset 
of the psychiatric disorders. However, for the state of severe 
malnutrition and the organ complications, our patient is 
similar to subjects with anorexia nervosa. Chronic mal-
nutrition and anorexia nervosa are often complicated by 
endocrine dysregulation (hypogonadism, hypercortisolism, 
GH-resistance, altered regulators of hunger), fluid and 
electrolyte imbalances, cardiovascular and hemodynamic 
abnormalities (bradycardia and arrhythmia, hypotension, 
heart failure), haematological disorders, osteopenia and 
osteoporosis, increased serum levels of transaminases, amy-
lase and lipase that return within the normal range after an 
adequate nutritional and volaemic support. Anorexia nervosa 
is associated with a mortality rate of 5.6% per decade (1-3). 
High serum levels of amylase and lipase are often found 
in the absence of clinical and instrumental evidence of 
pancreatic damage (4-6). However, in patients with chronic 
malnutrition have also been found cases of idiopathic acute 
recurrent pancreatitis (7). After a review of the literature, 
we found a small number of reports describing severe liver 
injury and multiorgan dysfunction in anorexia nervosa. In 
12.2% of patients with anorexia nervosa, a moderate increase 
in transaminase levels was observed; other reports showed 
transaminase elevation in 50% of the cases.  Incidence and 
severity of hypertransaminasemia were greater in the patients 
with low BMI, especially in young men. Transaminase levels 
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>200 U/L were observed in 76% of patients with anorexia 
nervosa and a BMI <12 Kg/m2; however rare cases of severe 
hepatic impairment was reported (8-9). Despite a probable 
multiorgan injury, in our patient the high levels of transa-
minases and pancreatic enzymes were the most important 
biochemical abnormalities found which normalized after 
refeeding. The mechanism of hypertransaminasemia is un-
clear. According to several studies, it is probably caused by 
ischaemic hepatitis secondary to liver hypoperfusion. Chro-
nic malnutrition is in fact associated with dehydration, hypo-
volemia, decreasing in cardiac output, marked hypotension 
and arrhythmias secondary to electrolyte imbalance which 
may be exacerbated during refeeding. Our patient showed 
no signs of cardiac dysfunction, but severe dehydration and 
hypotension may have been responsible for the reduction in 
the liver perfusion. Other hypothesis which might lead to 
liver injury involves changes in hepatocyte lipid metabolism 
(increased production of triglycerides associated to decre-
ased beta-oxidation of fatty acids), the selenium deficiency 
followed by the reduction of glutathione-peroxidase activity 
and increased oxidative stress and iron accumulation in hepa-
tic cells. In some cases, imaging and histologic studies have 
detected a fatty liver. The largest series of liver biopsy have 
showed glycogen depletion, trabecular atrophy, sinusoidal 
fibrosis, autophagosomes or the presence of aggregates of 
Kupffer cells. It has been reported that steatohepatitis simi-
lar to NASH can occur in patients during total parenteral 
nutrition (9-14).
However the cause of hypertransaminasemia is not only 
due to liver injury but to a multiorgan injury, as suggested 
Fig. 1. Evolution of biological parameters during hospitalization.
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by the elevated CK and LDH levels found in this patient 
and in several other cases described in literature in which 
increased levels of non-hepatic isoforms of LDH have also 
been shown (15). A transient increase in transaminases 
also occurs after refeeding. An inadequate nutritional tre-
atment may cause the refeeding syndrome. This syndrome 
is defined by a severe and potentially fatal fluid and elec-
trolyte imbalance, associated with metabolic abnormalities 
occurring in malnourished patients undergoing refeeding, 
whether orally, enterally, or parenterally (16). It is cha-
racterized by neurological symptoms (delirium, lethargy, 
coma), nausea, respiratory and heart failure, hypotension, 
arrhythmias, hematologic disorders (anemia, thrombocyto-
penia, abnormal leukocyte function). Hypophosphatemia 
is the most frequently observed abnormality in association 
with hypomagnesemia, hypokalaemia, vitamin deficiencies 
(thiamine) and hypoalbuminemia. Once the subjects at risk 
of refeeding syndrome are detected, it is advisable to start 
with a caloric intake of 5-10 kcal/kg per day and to incre-
ase slowly. Vitamin supplements (thiamine and vitamin B 
complex) should be started straight away and fluid balance 
carefully controlled. In order to prevent the hypophospha-
temia a glucose intake of 4-7 mg/Kg/min and a phosphate 
supplement (31-62 mg/100 kcal) is recommended (17, 18). 
Mild asymptomatic hypoglycemia is commonly found in 
anorexia; cases of hypoglycemic coma, often associated 
with hepatic impairment, are rare. Hypoglycemia is an 
unfavorable prognostic factor in these patients. The correct 
pathogenesis of hypoglycemia has not been elucidated but 
several mechanisms including depletion of liver glycogen, 
glucagon secretion deficiency and decreased gluconeogene-
sis have been proposed (19). In our patient haematogical test 
showed thrombocytopenia, leukopenia (with lymphocyto-
penia), anemia and increased levels of ferritin and vitamin 
B12. Anemia and leukopenia are found in approximately 
one-third of the anorexic subjects while thrombocytopenia in 
11.5%. The reticulocyte count is usually normal or reduced. 
Iron deficiency is an uncommon finding in these patients, 
especially in males. The ferritin levels, elevated in 30% 
of cases, are reduced to the normal range after refeeding. 
Vitamin B12, folate and erythropoietin levels are usually 
normal; the latter increase significantly during the refeeding 
with weight gain. Leukopenia was observed in 29-36% of 
the cases. Granulocytopenia, lymphocytopenia and normal 
lymphocytes T/B ratio are frequent (20), although the exact 
pathogenic mechanisms of these features remain unclear. In 
the 50% of patients with anorexia nervosa and hematolo-
gical changes in the peripheral blood count, signs of bone 
marrow hypoplasia and less frequently a complete atrophic 
transformation with deposition of amorphous material were 
observed. This alteration has been described as “gelatinous 
degeneration”. It would be secondary to a chronic deficit 
of carbohydrates and it regresses rapidly after an adequate 
refeeding to which the use of hematopoietic growth factors 
have been associated (21, 22). Altered levels of inflammatory 
cytokines (1L-1, IL-6, TNF-α) and leptin may also contri-
bute to the genesis of hematopoietic disorders (23). In our 
case the haematological disorders found on admission seem 
to be the result of the severe state of malnutrition. Anemia, 
treated with red blood cell transfusion and erythropoietin, 
could depend on the refeeding syndrome. After the nutri-
tional treatment, a normalization of the blood platelet count 
associated with a slightly increase of the leukocyte has been 
observed. Osteopenia and osteoporosis are further complica-
tions of chronic malnutrition. In a group of adult women with 
anorexia the prevalence of osteopenia would reach 92%. A 
reduction in bone mineral density (BMD) was observed in 
41% of female adolescents and in 35% of anorexic young 
males. Possible causes involve the hypoestrogenism and 
the hypoandrogenism, the hypercortisolism, the reduction 
of IGF-1 associated with GH-resistance, the high levels of 
appetite regulators such as ghrelin and peptide YY (24). Our 
patient showed severe osteoporosis, low levels of vitamin D3 
and testosterone, increased levels of PTH and cortisol.
 
Conclusions
In this case the association of chronic malnutrition and 
the decrease in systemic perfusion, secondary to dehydra-
tion and hypotension, may be responsible for multiorgan 
injury. In our patient the high levels of transaminases and 
pancreatic enzymes were the most important biochemical 
abnormalities normalized after refeeding.
A treatment strategy aimed at the nutritional support and 
at the correction of the electrolyte imbalance associated with 
the supplement of thiamine and erythropoietin was helpful 
in achieving a favorable outcome.
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